<DOC>
	<DOC>NCT01288625</DOC>
	<brief_summary>The purpose of this study is to compare the incidence of stomatitis when treating with amifostine before radiation treatment.</brief_summary>
	<brief_title>Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine</brief_title>
	<detailed_description />
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<mesh_term>Amifostine</mesh_term>
	<criteria>1. 1870 years old, male or female 2. Primary treatment of phase IIVA head and neck cancer patients, identified by histological and pathological diagnosis 3. Postoperative patients should receive radiation treatment in 12 weeks 4. ECOG &lt;2 5. Expected lifetime â‰¥6months 6. No severe complications (hypertension, CHD, diabetes and psychiatric history, etc.) 7. Not involved in other clinical trials 8. Sign ICF 1. ECOG &gt;2 2. Suffered other cancers in the past 5 years 3. Received amifostine treatment in the past 4 weeks 4. Unable to complete treatment or sign ICF because of medical or physical reasons</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Identify whether Cytofos can reduce the incidence and duration of HNC patients' oral mucositis caused by radiotherapy.</keyword>
</DOC>